Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Is a | Type of drug preparation | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Is a | forme pharmaceutique pour usage transdermique et/ou cutané | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Is a | Basic dose form with semi-solid state of matter (basic dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Has state of matter (attribute) | Semi-solid | true | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Dithranol 10 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Haloprogin 1% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Clioquinol + hydrocortisone 3%ww/0.5%ww cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ciclopirox olamine 1% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely permethrin stain 50 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Podophyllotoxin 1.5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Dithranol 0.1% cream (product) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely imiquimod 37.5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Dithranol 0.4% cream (substance) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely fluprednidene acetate 1 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Anthralin 0.2% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Iodoquinol+hydrocortisone 1%/1% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Butoconazole nitrate 2% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Benzoyl peroxide+potassium hydroxyquinoline sulfate 10/0.5% cream (substance) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ciclopirox 0.77% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Silver sulfadiazine 10mg/g cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely coal tar 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Pimecrolimus 10mg/g cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Anthralin cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Nystatin + triamcinolone acetonide 100000unt/1mg cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Amorolfine (as amorolfine hydrochloride) 2.5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Sertaconazole 2% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Clioquinol+hydrocortisone 3%/0.5% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Hydroquinone 40mg cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Hydroquinone 40mg/gram cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Electrode cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Hydroquinone 40 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Penciclovir 10 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Conventional release nasal cream (dose form) | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Rectal cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Conventional release vaginal cream (dose form) | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Cutaneous cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
crème buccale à libération conventionnelle | Has basic dose form (attribute) | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Eye cream (product) | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ear cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Conventional release transdermal cream (dose form) | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Oromucosal cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Existential restriction modifier (core metadata concept) |
Start Page 2 of 2
This concept is not in any reference sets